Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Kidney International
|
August 1, 1997
Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement
A Argilés, A Ficheux, M Thomas, et al.
Shock (Augusta, Ga.)
|
December 19, 2017
Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac Arrest
Pirkka T Pekkarinen, Giuseppe Ristagno, Erika Wilkman, et al.
Infectious Diseases Now
|
February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical care
A-L Beaumont, D Vignes, R Sterpu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
P F Conte, M V Dieci, G Bisagni, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Kidney International
|
August 1, 1997
Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement
A Argilés, A Ficheux, M Thomas, et al.
Shock (Augusta, Ga.)
|
December 19, 2017
Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac Arrest
Pirkka T Pekkarinen, Giuseppe Ristagno, Erika Wilkman, et al.
Infectious Diseases Now
|
February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical care
A-L Beaumont, D Vignes, R Sterpu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
P F Conte, M V Dieci, G Bisagni, et al.
Page
of 7